Regulatory Risk
Breaking
Macro
Kennedy Health Officials Explored Banning Antidepressants, Threatening Access for 16 Million Americans
Preliminary HHS inquiry into restricting SSRIs signals potential regulatory inflection point for psychiatric drug policy despite administration denials.
Markets
SEC Fraud Probe Exposes $2.5 Trillion Blind Spot in Private Credit
Regulatory investigation reveals transparency crisis in alternative lending sector as redemption pressures mount and default projections approach pandemic levels.